3D printing (additive manufacturing) has moved from “future technology” to real-world pharmaceutical application in India. In 2026 many B.Pharm students are choosing 3D printing related topics for final-year projects because the Union Budget 2025–26 allocated funds under Biopharma SHAKTI for advanced manufacturing and personalized medicine.
This guide explains current trends, most popular project ideas and how to make your project stand out.
Why 3D Printing is Trending for B.Pharm Students in 2026
- Allows true personalized medicine (dose, shape, release profile tailored to patient)
- Reduces manufacturing waste compared to traditional tableting
- Enables polypills (multiple drugs in one tablet) → better patient compliance
- Strong syllabus connection (Novel Drug Delivery Systems + Industrial Pharmacy)
- High publication potential (many journals now accept 3D-printed formulation work)
- Growing industry demand — Indian companies like Aequus, FabRx partners & startups hiring
Most Demanded 3D Printing Project Ideas for B.Pharm (2026)
-
Development & Evaluation of 3D-Printed Immediate-Release Tablets
- Drug: paracetamol / metformin / atorvastatin
- Focus: printability, hardness, disintegration time, comparison with commercial tablet
-
3D-Printed Polypill Containing 2–4 Cardiovascular Drugs
- Drugs: aspirin + atorvastatin + ramipril ± metoprolol
- Goal: controlled sequential release layers
-
Orodispersible Films (ODFs) / Fast-Dissolving Tablets by Semi-solid Extrusion
- Drugs: ondansetron, tadalafil, montelukast
- Target population: geriatrics / pediatrics
-
Floating Gastroretentive Tablets by FDM 3D Printing
- Drug: metformin / famotidine
- Evaluation: buoyancy time, in-vitro drug release
-
3D-Printed Chewable Tablets for Pediatric Use
- Drug: albendazole / azithromycin
- Focus: palatability, mechanical strength, taste masking
Key Characterization Tests You Should Include (for good marks & publication)
- Dimensional accuracy & weight uniformity
- Mechanical properties (hardness, friability)
- Surface morphology (SEM / optical microscopy)
- In-vitro dissolution / disintegration
- Drug content & content uniformity
- Stability study (accelerated condition)
- Comparison with conventional marketed product
Common Challenges & Practical Solutions
- Nozzle clogging → optimize filament temperature & drug loading
- Poor layer adhesion → use suitable polymers (PVA, PLA, HPC, Eudragit)
- High drug load difficult → use semi-solid extrusion instead of FDM
- Regulatory uncertainty → focus on “point-of-care” or “compounding” angle
- Equipment access → collaborate with pharmacy colleges / IITs / startups that have printers
2026–2027 Future Outlook for B.Pharm Students
- More colleges buying desktop FDM & SSE printers
- CDSCO draft guideline on 3D-printed dosage forms expected
- Rise of “pharmacy compounding + 3D printing” model in hospitals
- Startups focusing on orphan drugs & pediatric formulations
- Strong placement advantage if project includes QbD + DoE
Quick Start Checklist for Your Project
- Choose BCS class II/IV drug with solubility issue
- Select printer type (FDM most common & affordable)
- Finalize polymer(s) – PVA, HPMC, Soluplus, Eudragit EPO
- Use Design-Expert / Minitab for DoE (very impressive in viva)
- Include at least one marketed product comparison
- Write strong discussion on personalized medicine & patient compliance
3D printing projects are currently among the top 5 most discussed B.Pharm topics in 2026 placement interviews and conferences.